Neo-DAB: Darolutamide and Abemaciclib in Prostate Cancer | stella

Learn Data Labs For Researchers Find trials matched to me

Learn Data Labs For Researchers Find trials matched to me →

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Privacy ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Neo-DAB: Darolutamide and Abemaciclib in Prostate Cancer | stella

Back to Metastatic Prostate Cancer trials

Completed

Plain-English translation of NCT05617885 on ClinicalTrials.gov ↗ · Source last updated June 2026 · How we translate trials

Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.

Trial locations(1 site)

United States

Dana-Farber Cancer Institute, Boston, Massachusetts

Key details

Phase

Safety & dosing

Sponsor

Praful Ravi, MB BCHir, MRCP

Collaborators

Eli Lilly and Company, Bayer

Enrollment target

~9 participants

Started

August 2023

Primary completion

July 2025

View full record on ClinicalTrials.gov

Age range

18 Years and older

Sex

Male only

Last updated on clinicaltrials.gov in June 2026.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.